Published by Peptide Protocols · Reviewed September 2026 · How we make these pages · Educational & research purposes only — not medical advice.
As the GLP-1-class conversation matures, more "dual" and "triple" compounds enter the research picture. Survodutide is one of the notable ones — a dual GLP-1/glucagon receptor agonist — and it's studied for a second area beyond weight: the liver.
Survodutide engages two receptor pathways: GLP-1 (appetite and metabolic signaling) and glucagon (which influences energy expenditure and liver-fat metabolism). That glucagon component is the reason it's studied not just for body weight but also for metabolic liver conditions (the research area often abbreviated MASH/NASH).
So survodutide and retatrutide share the glucagon angle; retatrutide adds a third pathway. For the foundational comparison, read tirzepatide vs semaglutide and retatrutide.
And as with the whole class, appetite reduction that's strong enough to move weight can also cost lean muscle without deliberate protein intake and resistance training.
Vial mg + bacteriostatic water mL + your target mcg → mL and U-100 syringe units, instantly. Free, no sign-up, 60+ research peptides preset — plus dedicated calculators and BAC-water charts for BPC-157, retatrutide, tirzepatide, semaglutide, tesamorelin and CJC-1295/ipamorelin.
Open the free peptide calculator →Research & educational use only — never medical advice.
We do not recommend or partner with any peptide supplier. Use the checklist instead: third-party COAs that match your batch and lot, stated purity, clear research-use labeling, real support and proper cold-chain shipping.
The supplier checklist →Educational content only. Confirm the legal status where you live before ordering anything.
It's a dual GLP-1/glucagon agonist, and the glucagon arm is why it's studied for metabolic liver health (MASH/NASH) in addition to body weight.
No — as of 2026 it's investigational, still in the clinical pipeline. See our FDA status guide for context.
Both hit the glucagon pathway. Retatrutide adds a third pathway (GIP) on top of GLP-1 and glucagon; survodutide is the two-pathway GLP-1/glucagon version.
The Universal Logbook and reconstitution tools keep your notes clean and the math done for you across any compound you study.
Browse the shop on Etsy →The one formula, a BAC-water chart, and the 10 most-researched beginner peptides — the math done for you. Print it for the fridge.
🎁 Send me the free cheat sheet →